
Mayank Rajeev Kedia
About Mayank Rajeev Kedia
Data last updated:
Mayank Rajeev Kedia is a Director at Finebiotics Pharma Limited (since 2020) and Designated Partner at Unotex Pharma Llp (since 2022). The companies operate in Pharma and Business Services. The largest current company by reported revenue is Finebiotics Pharma Limited at ₹26.36 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Jul 2020 | 2004 | ₹26.36 Cr (FY 2025) | Active | |
| Designated Partner | 13 Nov 2022 | 2022 | Active |
Board colleagues of Mayank Rajeev Kedia
| Name | DIN | Company | Designation |
|---|---|---|---|
| Mukesh Tarachand Agarwal | 00118813 | Finebiotics Pharma Limited | Director |
| Niraj Kumar Harodia | 06676837 | Finebiotics Pharma Limited | Director |
| Parshva Shashikant Jhaveri | 02869621 | Finebiotics Pharma Limited | Director |
| Pradipbhai Ratilal Shah | 06381840 | Finebiotics Pharma Limited | Director |
| Rohan Premshanker Seth | Finebiotics Pharma Limited | Cfo | |
| Sejal Amit Bhatia | Finebiotics Pharma Limited | Company Secretary | |
| Vedprakash Amarchand Agarwal | 03504243 | Finebiotics Pharma Limited | Whole-Time Director |
| Vivek Rajgarhia | 00225406 | Finebiotics Pharma Limited | Director |
| Priyanka Ramesh Lohia | 08650862 | Unotex Pharma Llp | Designated Partner |
| Rajeevkumar Purshottam Kedia | 02322333 | Unotex Pharma Llp | Designated Partner |
| Sunitakumari Rajeevkumar Kedia | 01860631 | Unotex Pharma Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mayank Rajeev Kedia
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mayank Rajeev Kedia
Mayank Rajeev Kedia currently holds 2 directorships: Finebiotics Pharma Limited (Director, since 01 Jul 2020, revenue ₹26.36 Cr (FY 2025)); Unotex Pharma Llp (Designated Partner, since 13 Nov 2022).
Mayank Rajeev Kedia was first appointed on 01 Jul 2020 as Director at Finebiotics Pharma Limited. The most recent appointment on record is 13 Nov 2022 at Unotex Pharma Llp.
The current boards of Mayank Rajeev Kedia's companies include Mukesh Tarachand Agarwal (Finebiotics Pharma Limited), Niraj Kumar Harodia (Finebiotics Pharma Limited), Parshva Shashikant Jhaveri (Finebiotics Pharma Limited), Pradipbhai Ratilal Shah (Finebiotics Pharma Limited), Rohan Premshanker Seth (Finebiotics Pharma Limited), Sejal Amit Bhatia (Finebiotics Pharma Limited), among others.